Nicotinamide Riboside: A Powerful Support for Cellular Health and Longevity
Nicotinamide Riboside (NR) is a type of vitamin B3 that plays a crucial role in the body's energy production and cellular health It is converted into Nicotinamide Adenine Dinucleotide (NAD+) in the body, a coenzyme present in all living cells and critical for various biological processes.
Supplement Summary
| Name | Nicotinamide Riboside (NR) |
|---|---|
| Category | Vitamins & Minerals |
| Main Uses |
|
| Effectiveness | Moderate to High, depending upon individual response and regularity of use |
| Common Dosage | 100-300mg daily |
| Price Range | $25-$50 per month |
| Forms Available | Capsules Powder |
Pros
- ✅ Boosts NAD+ levels
- ✅ Supports cellular health
- ✅ May slow down aging
- ✅ Supports brain function
- ✅ Supports heart health
Cons / Side Effects
- ❌ More research is needed
- ❌ Potential side effects like nausea and fatigue
- ❌ Can be expensive
What Is Nicotinamide Riboside (NR)?
How It Works
Who It's Best For
Who Should Avoid It
Dosage & Usage Tips
Buying Advice & Quality Tips
Price & Value
Final Verdict
Additional Clinical Research
RESEARCH SUMMARY: Nicotinamide Riboside (NR)
KEY FINDINGS:
Metabolic Health
- NR supplementation at 2,000 mg/day for 12 weeks was safe but did not improve insulin sensitivity or glucose metabolism in obese, insulin-resistant men.
- Study details: Randomized, placebo-controlled, double-blind trial with 40 sedentary men aged 40–70 years and BMI >30 kg/m².
Source: Dollerup et al. (2018)
Neurodegenerative Diseases
- NR supplementation at 1,000 mg/day for 30 days was well tolerated and led to increased cerebral NAD levels in patients with Parkinson's disease, associated with altered cerebral metabolism and mild clinical improvement.
- Study details: Double-blind, randomized phase I trial with 30 newly diagnosed, treatment-naive Parkinson's disease patients.
Source: Tzoulis et al. (2022)
Cognitive Function
- NR supplementation at 1,000 mg/day for 10 weeks was safe and increased blood NAD+ levels but did not alter cognitive function in older adults with mild cognitive impairment.
- Study details: Placebo-controlled, randomized pilot study with 20 subjects aged 55–79 years.
Source: Orr et al. (2023)
RESEARCH QUALITY ASSESSMENT:
- All studies were randomized, placebo-controlled, and double-blind, enhancing the reliability of the findings.
- Sample sizes were relatively small, which may limit the generalizability of the results.
- Study durations ranged from 4 to 12 weeks; longer-term effects of NR supplementation remain unknown.
- Further large-scale, long-term studies are needed to fully understand the potential health benefits and risks of NR supplementation.

